Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02875067
Title Safety & Efficacy Study of Combination of Pembrolizumab and Lenalidomide, in Patients With Relapsed Non-Hodgkin and Hodgkin Lymphoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors New York University School of Medicine
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Hospital Atlanta Georgia 30322 United States Details
Massachusetts General Hospital Boston Massachusetts 02114 United States Details
NYU Perlmutter Cancer Center New York New York 10016 United States Details
*Shaded cells indicate that there was no data available from for the field